At UT MD Anderson, we are committed to advancing the quality of and access to cancer care across the globe. Supported by unparalleled resources and a culture of collaborative science, our researchers pursue bold hypotheses and test innovative ideas that drive breakthroughs and transform results to meet our goal of eliminating the global cancer burden.
At the European Society for Medical Oncology (ESMO) Congress, UT MD Anderson experts showcase the latest advances in cancer care and lead critical conversations on translating these discoveries into clinical practice to benefit patients worldwide.
Explore our presentation highlights and learn more about our global reach below.
Featured Article
UT MD Anderson joins global consortium committed to eliminating cervical cancer
The collaboration agreement with the Elimination Partnership in Cervical Cancer (EPICC) expands UT MD Anderson’s global oncology efforts, further strengthening its commitment to advancing cancer prevention and control in medically underserved regions. Read more about the collaboration
Our research by the numbers
$1.3B
invested in research
1,579
clinical trials in FY25
140
patents awarded to UT MD Anderson in FY25
Our Global Reach
UT MD Anderson has one singular mission: to end cancer. But we can’t do it alone. A future without cancer requires that we work together — locally, nationally and globally — to improve care for cancer patients, fuel groundbreaking research, and implement evidence-based prevention and screening approaches. Learn about our international collaborations aimed at advancing global cancer care.
A few of our collaborators
-
World Health Organization (WHO)
MD Anderson and WHO establish new international collaboration to reduce women’s cancers
-
Pan American Health Organization (PAHO)
MD Anderson and Pan American Health Organization join forces to support cancer prevention and control in the Americas
-
International Atomic Energy Agency (IAEA)
MD Anderson designated IAEA Collaborating Centre to focus on improving radiation, radiology and nuclear medicine worldwide
-
Ministry of Health in Mozambique
MD Anderson announces new initiatives in Mozambique and Brazil to advance cancer prevention, treatment, research and education efforts
-
Ministry of Health in Indonesia
MD Anderson announces new collaboration in Indonesia to reduce global cancer burden
Education and Training at UT MD Anderson
UT MD Anderson academic programs are competitive and comprehensive. We offer educational opportunities from undergraduate degrees to graduate medical education opportunities.
Institutes at UT MD Anderson
United by a shared mission to end cancer, UT MD Anderson clinicians and scientists work seamlessly together to advance groundbreaking research that can transform the field of hematology. Leveraging our unique research ecosystem, including three leading institutes, we are pioneering new prevention, diagnostic and treatment approaches to address the most pressing needs for patients with cancer.
The James P. Allison Institute is dedicated to advancing exceptional discovery, translational and clinical research to integrate immunobiology across disciplines and unlock the full potential of science and medicine for human health. The institute builds upon the legacy of its namesake, James P. Allison, Ph.D., who was awarded the 2018 Nobel Prize in Physiology or Medicine for his fundamental discoveries in T cell biology and his invention of ipilimumab, the first immune checkpoint inhibitor to treat cancer.
Building upon unparalleled expertise, the Institute for Cell Therapy Discovery & Innovation is leading the world in developing and advancing impactful cell therapies for patients in need. By uniting the top minds in the field to lead exceptional fundamental, translational and clinical research, we're focused on creating breakthrough off-the-shelf therapies that can be readily adapted for both hematologic and solid tumors as well as devastating auto-immune conditions, infections and other diseases.
Learn more about the Institute for Cell Therapy Discovery & Innovation
The Institute for Data Science in Oncology (IDSO) integrates the tremendous power of meaningful data extraction and interpretation with UT MD Anderson’s unparalleled scientific and clinical expertise to transform research and care to impact patients.